Kriya Therapeutics Stock

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

Sign up today and learn more about Kriya Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Kriya Therapeutics Stock

Kriya Therapeutics is a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy. They have built a fully integrated engine that consolidates the critical infrastructure and technology needed to engineer, manufacture, characterize, and develop new gene therapies

Funding History

May 2020$80.5M
July 2021$100M
May 2022$270M
July 2023$150M

Management

President and Chief Medical Officer

Ma'an Muhsin

Co-Founder

Fraser Wright

Board Member

Keith Manchester

Chief Medical Officer & President- Kriya Ophthalmology

Theresa Heah

Chief Scientific Advisor

Fraser Wright

Co-Founder and Chief Executive Officer

Shankar Ramaswamy

Investor

Jeff Bird

President and COO

Curt Herberts

Co-Founder & Vice Chairman

Roger Jeffs

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo